Reviewing the prognostic factors in myelomeningocele

Area of Science:

• Pediatric Neurosurgery
• Developmental Biology
• Clinical Neurology

Background:

• Myelomeningocele (MMC) is a complex congenital condition with significant lifelong morbidity and mortality risks.
• Understanding factors influencing outcomes in MMC patients is crucial for improving clinical management and patient prognosis.

Purpose of the Study:

• To analyze demographic, clinical, and surgical factors impacting morbidity and mortality in myelomeningocele (MMC) patients.
• To identify key predictors of adverse outcomes and complications in a cohort of pediatric MMC patients.

Main Methods:

• Retrospective cohort study of 231 pediatric patients undergoing primary MMC repair.
• Analysis of variables including gestational age, birth weight, head circumference, MMC level, hydrocephalus, urinary tract infections (UTIs), and surgical interventions (shunt placement, revisions).
• Minimum follow-up of 1 year, with data collected from medical records between 1995 and 2015.

Main Results:

• Shunt failures (47.2% of hydrocephalus cases) and recurrent UTIs (55.8% of MMC cases) were primary causes of hospitalization and death.
• Macrocephaly (head circumference ≥ 38 cm at birth) was a significant risk factor for shunt revision (p < 0.001).
• Higher spinal defect levels were associated with increased shunt placement frequency and recurrent UTIs, while lumbar MMC levels showed less revision need.

Conclusions:

• Macrocephaly at birth and higher myelomeningocele defect levels are associated with poorer patient outcomes.
• These factors present significant challenges in the daily clinical practice of pediatric neurosurgeons managing MMC patients.